This inventor holds 6 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The Government of the United States of America, as Represented by the. Active years: 1990-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 1,217 
1 out of 28 
Years Active: 1990-1998
Title: Markku I Linnoila: Innovator in Serotonin Receptor Research
Introduction
Markku I Linnoila is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of genetics and pharmacology, particularly in the study of serotonin receptors. With a total of 6 patents, his work has implications for understanding various psychological and physiological conditions.
Latest Patents
One of Linnoila's latest patents is focused on the allelic variation of the serotonin 5HT7 receptor. This invention describes an allelic variant of the 5HT7 serotonin receptor that has been correlated with alcoholic offenders based on family study data. The patent includes DNA encoding the variant protein, the protein itself, vectors containing the variant gene, and cell lines carrying a vector with the variant gene. Another significant patent involves the allelic variation of the serotonin 5HT2C receptor. This work identifies a non-conservative amino acid substitution in the 5-HT2C receptor gene, discovered through single strand conformational polymorphism (SSCP) analysis. The gene was genetically mapped on the long arm of the X chromosome, and a PCR-RFLP based method was developed for rapid genotyping in populations and families.
Career Highlights
Linnoila has worked with the United States of America as represented by the Department of Health and the Government of the United States of America. His research has been pivotal in advancing the understanding of serotonin receptors and their genetic variations.
Collaborations
Throughout his career, Linnoila has collaborated with notable individuals such as David Goldman and Matti Virkkunen. These collaborations have contributed to the depth and breadth of his research.
Conclusion
Markku I Linnoila's innovative work in serotonin receptor research has led to important discoveries that enhance our understanding of genetic variations and their implications. His contributions continue to influence the fields of genetics and pharmacology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile